MiNK Therapeutics Inc (NASDAQ:INKT) traded at $64.17 at close of the session on Friday, July 11 and made an upward move of 730.14% on its previous day’s price.
Looking at the stock we see that its previous close was $7.73 and the beta (5Y monthly) reads 0.148 with the day’s price range being $20.2 – $76.0. In terms of its 52-week price range, INKT has a high of $13.79 and a low of $4.56. The company’s stock has gained about 746.77% over that past 30 days.
MiNK Therapeutics Inc has a market cap of $255.76 million and is expected to release its quarterly earnings report on 2025-May-15.
On the other hand, looking at the outlook for the INKT stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 100% Buy.
Looking further, we note the current price level is 529.14% off its SMA20 and 658.48% from its 50-day simple moving average. The RSI (14) is pointing at 98.11 while the volatility over the past week is 59.93% and jumps to 17.72% over the past one month.
Coming back to MiNK Therapeutics Inc (NASDAQ:INKT), we note that the average 3-month trading volume was 7.55K, while that of the preceding 10-day period stands at 4.77 million. Current shares outstanding are 3.97 million.
The insiders hold 75.14% of the company’s shares while institutions hold 1.58%. The data shows that short shares as of 2025-06-13, stood at 10657.0 at a short ratio of 2.44. This represents a 103.00 short interest in shares outstanding on 2025-06-13. Shares short fall in June from the previous month at 21964.0. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock 620.53% up in year-to-date price movement.
